Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

22
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

15
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stem Cell Transplantation in Friedreich Ataxia: Cure for Leukemia but No Effect on Neurological Progression.

Annals of clinical and translational neurology·2026
Same author

Advances in Gene and Cellular Therapy in Friedreich Ataxia.

Molecular diagnosis & therapy·2026
Same author

FXN protomutations are the source of pathogenic expanded GAA alleles in Friedreich ataxia and explain its unequal population distribution.

Human molecular genetics·2026
Same author

Compound Heterozygote Friedreich Ataxia Patients With Covert Proximal FXN Gene Deletions.

Annals of clinical and translational neurology·2026
Same author

Listening in Spatialized Noise-Sentences (LiSN-S) as a Measure of Auditory Function in Friedreich Ataxia.

Cerebellum (London, England)·2026
Same author

Safety and efficacy of individualised exercise and NAD<sup>+</sup> precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

The Lancet. Neurology·2026

Related Experiment Video

Updated: May 4, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

10.6K

Glutamatergic autoencephalitides: an emerging field.

Jessica A Panzer1, Amy J Gleichman, David R Lynch

  • 1Division of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA, panzer@email.chop.edu.

Journal of Neural Transmission (Vienna, Austria : 1996)
|January 10, 2014
PubMed
Summary

Autoimmune diseases targeting synaptic proteins, like N-methyl-D-aspartate receptors (NMDARs), cause neurological and psychiatric symptoms. Immunotherapy shows promise for these conditions linked to antibody-mediated receptor dysfunction.

More Related Videos

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

9.5K
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

15.6K

Related Experiment Videos

Last Updated: May 4, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

10.6K
A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

9.5K
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

15.6K

Area of Science:

  • Neuroimmunology
  • Synaptic Physiology
  • Autoimmune Neurology

Background:

  • Autoimmune responses against synaptic proteins can cause diverse neurological symptoms.
  • Antibodies targeting ionotropic glutamate receptors, such as N-methyl-D-aspartate receptors (NMDARs) and AMPA receptors (AMPARs), are implicated in several disorders.
  • Anti-NMDAR encephalitis is characterized by psychiatric features, seizures, movement disorders, and autonomic dysfunction, often associated with ovarian teratomas and responsive to immunosuppression.

Purpose of the Study:

  • To review the understanding of disorders associated with anti-glutamate receptor antibodies.
  • To highlight the pathophysiological mechanisms involving antibodies against NMDARs.
  • To discuss the implications for diagnosis and treatment of these conditions.

Main Methods:

  • Review of literature on autoimmune encephalitis and anti-glutamate receptor antibodies.
  • Analysis of clinical presentations and immunological findings in affected patients.
  • Discussion of the link between antibody binding, synaptic function, and receptor hypofunction.

Main Results:

  • Antibodies to NMDARs bind to the amino terminal domain, leading to synaptic NMDAR loss and hypofunction.
  • Anti-NMDAR antibodies are found in various neuropsychiatric conditions, including psychosis and dementia.
  • The presence of these antibodies suggests a potential role for immunotherapy in certain disorders.

Conclusions:

  • Disorders involving anti-glutamate receptor antibodies have significantly advanced our understanding of neurology.
  • These antibodies provide a direct link between basic science and clinical medicine by demonstrating the impact of neurotransmitter receptor loss.
  • Further research into their pathophysiology will improve treatments and offer insights into glutamate receptors' roles in cognition and neuropsychiatric diseases.